PROGRAM CHAIRS

Suresh T. Chari, MD, FACG
Professor of Medicine
Department of Gastroenterology and Hepatology
The University of Texas MD Anderson Cancer Center
Houston, Texas

Yasmin Hernandez-Barco, MD
Director, Center for Pancreatic Disease at Mass General Brigham
Assistant Professor, Harvard Medical School
Boston, Massachusetts
PROGRAM OVERVIEW
This whiteboard satellite symposium offers gastroenterologists and advanced practice professionals (nurse practitioners and physician assistants) a dynamic, visual exploration of immunoglobulin G4-related disease (IgG4-RD). Designed to address important clinical gaps, this symposium aims to break down the complex pathogenesis and clinical manifestations of IgG4-RD. Participants will gain practical strategies to utilize current diagnostic and classification criteria, enhancing their ability to accurately assess disease activity and improve diagnostic precision. Furthermore, the faculty will present recent clinical trial data for emerging targeted therapies, allowing the gastrointestinal care team to integrate evidence-based findings into personalized treatment plans that optimize patient outcomes.
TARGET AUDIENCE
This activity is designed to meet the educational needs of gastroenterologists and their associated advanced practice professionals.
LEARNING OBJECTIVES
Upon the completion of this program, learners should be able to:
- Describe the pathogenesis and clinical manifestations of IgG4-RD
- Utilize diagnostic and classification criteria for IgG4-RD to assess disease activity to improve diagnostic accuracy
- Integrate clinical trial data for targeted therapies to inform treatment strategies for patients with IgG4-RD
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.
AAPA CREDIT DESIGNATION STATEMENT – ENDURING MATERIALS
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until November 9, 2027. PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Suresh T. Chari, MD, FACG | Consulting Fees: Amgen, Olympus, Pfizer, Zenas Biopharma |
| Yasmin Hernandez-Barco, MD | Consulting Fees: Amgen, Nestle, Sanofi, Zenas BioPharma |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Andrew Grzybowski, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, COO of Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Vaidehee Deshpande, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC has nothing to disclose.
- La Donna Lue Winston, MSN, APRN, AGACNP-BC, SCRN, RN, has nothing to disclose.
- Abigail Dill, Program Manager for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use their clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group, prior to participating, at [email protected]
RELEASED DATE: November 09, 2026
EXPIRATION DATE: November 09, 2027

Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.